Refractory Hypocalcemia Induced by Denosumab and Nab-Paclitaxel in a Patient With Metastatic Breast Cancer.

Pervez MN, Ahmad H, Kashif M, Ur Rehman H

Open source

DOI
10.1016/j.aed.2026.02.011
Published
2026 Sep-Oct
Container
AACE endocrinology and diabetes
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.aed.2026.02.011,
  title = {Refractory Hypocalcemia Induced by Denosumab and Nab-Paclitaxel in a Patient With Metastatic Breast Cancer.},
  author = {Pervez MN and Ahmad H and Kashif M and Ur Rehman H},
  year = {2026},
  journal = {AACE endocrinology and diabetes},
  doi = {10.1016/j.aed.2026.02.011},
  url = {https://doi.org/10.1016/j.aed.2026.02.011}
}

RIS

TY  - JOUR
TI  - Refractory Hypocalcemia Induced by Denosumab and Nab-Paclitaxel in a Patient With Metastatic Breast Cancer.
AU  - Pervez MN
AU  - Ahmad H
AU  - Kashif M
AU  - Ur Rehman H
PY  - 2026
JO  - AACE endocrinology and diabetes
DO  - 10.1016/j.aed.2026.02.011
UR  - https://doi.org/10.1016/j.aed.2026.02.011
ER  - 

APA

MN, P., H, A., M, K., & H, U. R. (2026). Refractory Hypocalcemia Induced by Denosumab and Nab-Paclitaxel in a Patient With Metastatic Breast Cancer.. AACE endocrinology and diabetes. https://doi.org/10.1016/j.aed.2026.02.011

Source records